Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review (Q24607823)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review	scientific article

Statements

instance of

scholarly article

0 references

systematic review

1 reference

based on heuristic

inferred from title

review article

1 reference

stated in

Europe PubMed Central

title

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review (English)

0 references

main subject

chemotherapy

0 references

cannabinoids

0 references

systematic review

1 reference

based on heuristic

inferred from title

author name string

M R Tramèr

series ordinal

1

0 references

D Carroll

series ordinal

2

0 references

F A Campbell

series ordinal

3

0 references

D J Reynolds

series ordinal

4

0 references

R A Moore

series ordinal

5

0 references

H J McQuay

series ordinal

6

0 references

language of work or name

English

0 references

publication date

7 July 2001

0 references

published in

The BMJ

0 references

volume

323

0 references

issue

7303

0 references

page(s)

16-21

0 references

cites work

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

7 April 2017

Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

7 April 2017

The number needed to treat: a clinically useful measure of treatment effect

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

7 April 2017

An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Marijuana: medical implications

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Marihuana as medicine. A plea for reconsideration

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Nabilone: An Effective Antiemetic in Patients Receiving Cancer Chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Nabilone: an alternative antiemetic for cancer chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Medicinal applications of delta-9-tetrahydrocannabinol and marijuana

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

27 September 2017

Confidence intervals for the number needed to treat

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

30 May 2018

Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

30 May 2018

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

30 May 2018

Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

30 May 2018

A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

30 May 2018

Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

30 May 2018

A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

30 May 2018

Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

30 May 2018

Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

30 May 2018

delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

30 May 2018

Effect of nabilone on nausea and vomiting after total abdominal hysterectomy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34325

retrieved

28 November 2018

Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THC or Compazine for the cancer chemotherapy patient--the UCLA study. Part II: Patient drug preference

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabis and cancer chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhalation marijuana as an antiemetic for cancer chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologists

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In search of an effective antiemetic: a nusring staff participates in marijuana research

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

delta 9-tetrahydrocannabinol in clinical oncology

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiologic Observations in a Controlled Clinical Trial of the Antiemetic Effectiveness of 5, 10, and 15 mg of Δ9-Tetrahydrocannabinol in Cancer Chemotherapy. Ophthalmologic Implications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Controlled Substances Therapeutic Research Act in the State of Washington

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative Trial of the Antiemetic Effects of THC and Haloperidol

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiemetic Effect of Δ9-Tetrahydrocannabinol in Chemotherapy-Associated Nausea and Emesis As Compared to Placebo and Compazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabis and cancer chemotherapy. A comparison of oral delta-9-thc and prochlorperazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Levonantradol in the treatment of nausea and vomiting caused by cytostatic drugs (author's transl) clinical studies]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised multicentre single blind comparison of a cannabinoid anti-emetic (Levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Federal foolishness and marijuana

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cannabis remedy--wonder worker or evil weed?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11440936

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/BMJ.323.7303.16

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1672618

OpenCitations bibliographic resource ID

1672618

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1672618

PMC publication ID

34325

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1672618

PubMed publication ID

11440936

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1672618

ResearchGate publication ID

232265889

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24607823&oldid=1648955255"